A recent review in The Lancet examines non-celiac gluten sensitivity (NCGS), a condition where patients experience symptoms attributed to gluten consumption despite negative celiac disease tests. Approximately 10 percent of adults report gluten sensitivity, yet only 16-30 percent exhibit consistent symptoms in clinical trials, influenced by dietary variables like FODMAPs. The absence of validated biomarkers complicates diagnosis, which currently relies on exclusion of celiac disease and wheat allergy. The authors advocate for developing new biomarkers to enhance diagnostic accuracy and underscore the need for a collaborative approach among healthcare providers.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.
